Research Article
Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?
Table 1
ACT, APTT, anti-Xa, and UFH dose values.
| | | Total (N = 129) | Group without antithrombin deficiency (n = 27) | Group with antithrombin deficiency (n = 102) | value |
| | ACT (second) | 184 [175; 196] | 178 [168; 189] | 185 [175; 200] | 0.033 | | APTT (second) | 49 [40; 59] | 47 [42; 54] | 50 [40; 60] | 0.300 | | Anti-Xa (IU/ml) | 0,28 [0.21; 0.41] | 0,28 [0.24; 0.37] | 0.28 [0.19; 0.42] | 0.812 | | Heparin dose (IU/h) | 800 [600; 1000] | 600 [600; 800] | 800 [600; 1075] | 0.110 |
|
|
Data are presented as median [interquartile range].
|
